Althea UK and Ireland – a medical technology services provider – is now offering high quality and cost-effective SARS-CoV-2 Rapid Antigen Tests.
The antibody test – manufactured by Roche – can help detect SARS-CoV-2 infection in those suspected to carry the virus with results available in 15 minutes. The test can be used for both symptomatic and asymptomatic individuals.
Althea hopes that the new service, which is available for pharmacies, dentists, hospitals and clinics, as well as hospital support companies whose staff access clinical settings, will provide a valuable initial screening test for staff who might be exposed to COVID-19 or work in high-risk environments.
Healthcare workers remain a key high-risk group and regular testing was introduced for patient-facing staff at the end of last year to help protect primary care workers and curb the potential spread of COVID-19.
David Rolfe, CEO Althea said: “As COVID-19 continues to spread, and while vaccinations are being rolled out, testing remains crucial to contain the spread of COVID-19. We are pleased to be able to offer the Roche rapid antigen tests to support those providing vital services across the country with a reliable, high-quality testing option at an affordable price. At a time where budgets are stretched and health services are under pressure, as a trusted partner to many hospitals in the UK, we want to do our part in supporting those working on the frontline.”
Roche’s SARS-CoV-2 Rapid Antigen Test is a rapid chromatographic immunoassay and is performed using a nasopharyngeal swab. The test has a sensitivity of 96.52% and a specificity of 99.68% and helps to detect antibodies in individuals who have been exposed to the virus. Tests are for professional use and should be administered by healthcare or trained occupational health staff.
For more information visit: uk.covidtesting@althea-group.com
